Found 63 matching trials
T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-DP0401 Positive
PHASE1Background:
The National Cancer Institute (NCI) Surgery Branch has develop...
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Safety and Efficacy of MAGE-A3/A6 T Cell Receptor Engineered T Cells (KITE-718) in HLA-DPB1*04:01 Positive Adults With Advanced Cancers
PHASE1The primary objectives of Phase 1A are to evaluate the safety of KITE-718, ...
Location
Banner MD Anderson Cancer Center
Phase II Study to Assess the Safety and Immunogenicity of recMAGE-A3+AS15 ASCI With or Without Poly IC:LC
PHASE2The overall purpose of this research study is to find a better way to treat...
Location
H. Lee Moffitt Cancer Center and Research Institute
Melanoma Vaccine With Peptides and Leuprolide
PHASE2The goal of this clinical research study is to learn if the drug leuprolide...
Location
UT MD Anderson Cancer Center
Study of MAGE-A3 and NY-ESO-1 Immunotherapy in Combo With DTPACE Chemo and Auto Transplantation in Multiple Myeloma
PHASE2The hope is that the peptide vaccines will stimulate the immune system to a...
Location
University of Arkansas for Medical Sciences/MIRT
Tumor Markers Study in Gastric Cancer for Cancer Immunotherapy (ONCO-RD 010 CRT)
N/AGastric cancer is one of the leading causes of cancer-related deaths worldw...
Location
Multiple Locations
A Phase III Study to Test the Benefit of a New Kind of Anti-cancer Treatment in Patients With Melanoma, After Surgical Removal of Their Tumor
PHASE3The purpose of this clinical trial is to evaluate the benefit of the immuno...
Location
GSK Investigational Site
Study to Assess Safety and Immune Response of Stage IIB-IV Resected Melanoma After Treatment With MAGE-A3 ASCI
EARLY_PHASE1The goals of this study are to 1) assess the safety of recombinant MAGE-A3 ...
Location
University of Virginia
MG1-MAGEA3 With Ad-MAGEA3 and Pembrolizumab in Patients With Previously Treated Metastatic Melanoma or Cutaneous Squamous Cell Carcinoma
PHASE1This is a Phase 1b open-label dose escalation trial of Ad/MG1-MAGEA3 and Pe...
Location
Multiple Locations
A Trial of ChAdOx1 and MVA Vaccines Against MAGE-A3 and NY-ESO-1
PHASE1This clinical trial is looking at two new vaccines called ChAdOx1-MAGEA3-NY...
Location
Blackpool Victoria Hospital